Literature DB >> 14578848

Establishment, characterization, and long-term maintenance of cultures of human fetal hepatocytes.

Catherine A Lázaro1, Emma J Croager, Claudia Mitchell, Jean S Campbell, Changpu Yu, Jessica Foraker, Jonathan A Rhim, George C T Yeoh, Nelson Fausto.   

Abstract

Cultured human hepatocytes have broad research and clinical applications; however, the difficulties in culturing rodent and human hepatocytes are well known. These problems include the rapid loss of the hepatocytic phenotype in primary culture and the limited replicating capacity of the cultured cells. We describe the establishment of serum-free primary cultures of human fetal hepatocytes (HFHs) that retain hepatocytic morphology and gene expression patterns for several months and maintain sufficient proliferative activity to permit subculturing for at least 2 passages. Initially, HFH cultures contained 2 main cell types that morphologically resembled large and small hepatocytes. The fetal hepatocytes expressed alpha-fetoprotein (AFP), cytokeratin (CK) 19, albumin, and other hepatic proteins. Treatment of the cultures with oncostatin M (OSM) increased cell size and enhanced cell differentiation and formation of bile canaliculi, probably through an effect on hepatocyte nuclear factor (HNF) 4alpha. Approximately 1 month after plating, multiple clusters of very small cells became apparent in the cultures. These cells had very few organelles and are referred to as blast-like cells. Flow cytometric analysis of these cells showed that they express oval cell/stem cell markers such as CD90 (Thy-1), CD34, and OV-6 but do not stain with antibodies to beta(2)-microglobulin. HFH cultures maintained for 9 to 12 months produced grossly visible organoids containing ductular structures that stained for CK18, CK19, and AFP. In conclusion, HFH cultures, which might contain a population of hepatic stem cells, constitute an excellent tool for a variety of studies with human hepatocytes, including the mechanisms of viral infection.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14578848     DOI: 10.1053/jhep.2003.50448

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  57 in total

1.  Coexpression of CD14 and CD326 discriminate hepatic precursors in the human fetal liver.

Authors:  Marina E Fomin; Lung-Kuo Tai; Alicia Bárcena; Marcus O Muench
Journal:  Stem Cells Dev       Date:  2010-12-02       Impact factor: 3.272

2.  Gene expression profiling of extracellular matrix as an effector of human hepatocyte phenotype in primary cell culture.

Authors:  Jeanine L Page; Mary C Johnson; Katy M Olsavsky; Steven C Strom; Helmut Zarbl; Curtis J Omiecinski
Journal:  Toxicol Sci       Date:  2007-02-27       Impact factor: 4.849

3.  Hepatitis C virus replication in transfected and serum-infected cultured human fetal hepatocytes.

Authors:  Catherine A Lázaro; Ming Chang; Weiliang Tang; Jean Campbell; Daniel G Sullivan; David R Gretch; Lawrence Corey; Robert W Coombs; Nelson Fausto
Journal:  Am J Pathol       Date:  2007-02       Impact factor: 4.307

Review 4.  Hepatocyte polarity.

Authors:  Aleksandr Treyer; Anne Müsch
Journal:  Compr Physiol       Date:  2013-01       Impact factor: 9.090

5.  Formation of large vacuoles induced by cooperative effects of oncostatin M and dexamethasone in human fetal liver cells.

Authors:  Tamihide Matsunaga; Mie Toba; Tsuyoshi Teramoto; Mitsue Mizuya; Kaori Aikawa; Shigeru Ohmori
Journal:  Med Mol Morphol       Date:  2008-05-11       Impact factor: 2.309

Review 6.  Liver cancer stem cell markers: Progression and therapeutic implications.

Authors:  Jing-Hui Sun; Qing Luo; Ling-Ling Liu; Guan-Bin Song
Journal:  World J Gastroenterol       Date:  2016-04-07       Impact factor: 5.742

7.  Oncostatin M inhibits proliferation of rat oval cells, OC15-5, inducing differentiation into hepatocytes.

Authors:  Atsuhito Okaya; Junichi Kitanaka; Nobue Kitanaka; Makoto Satake; Yuna Kim; Kunihiko Terada; Toshihiro Sugiyama; Motohiko Takemura; Jiro Fujimoto; Nobuyuki Terada; Atsushi Miyajima; Tohru Tsujimura
Journal:  Am J Pathol       Date:  2005-03       Impact factor: 4.307

8.  Responses of nontransformed human hepatocytes to conditional expression of full-length hepatitis C virus open reading frame.

Authors:  Weiliang Tang; Catherine A Lázaro; Jean S Campbell; W Tony Parks; Michael G Katze; Nelson Fausto
Journal:  Am J Pathol       Date:  2007-11-08       Impact factor: 4.307

9.  Hepatocyte nuclear factor-4alpha induces transdifferentiation of hematopoietic cells into hepatocytes.

Authors:  Satish Khurana; Amit K Jaiswal; Asok Mukhopadhyay
Journal:  J Biol Chem       Date:  2009-12-16       Impact factor: 5.157

10.  Oncostatin M-stimulated apical plasma membrane biogenesis requires p27(Kip1)-regulated cell cycle dynamics.

Authors:  Sven C D Van IJzendoorn; Delphine Théard; Johanna M Van Der Wouden; Willy Visser; Kacper A Wojtal; Dick Hoekstra
Journal:  Mol Biol Cell       Date:  2004-07-07       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.